SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-053980
Filing Date
2009-03-13
Accepted
2009-03-13 17:06:03
Documents
8
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1011832
2 LOAN AND SECURITY AGREEMENT dex1053.htm EX-10.53 266668
3 SUBSIDIARIES OF REGISTRANT dex211.htm EX-21.1 1562
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 7530
5 RULE 13A-14(A) CERTIFICATION OF PEO dex311.htm EX-31.1 9525
6 RULE 13A-14(A) CERTIFICATION OF PFO dex312.htm EX-31.2 9554
7 SECTION 1350 CERTIFICATION OF PEO dex321.htm EX-32.1 4006
8 SECTION 1350 CERTIFICATION OF PFO dex322.htm EX-32.2 4040
  Complete submission text file 0001193125-09-053980.txt   1316158
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19825 | Film No.: 09681016
SIC: 2834 Pharmaceutical Preparations